Healthcare
Extendicare Inc.(EXETF)
Live Price
Offline$23.88
+2.14% today
1Y Change
+135.74%
Window
Jun 25, 2025 โ Jun 18, 2026
- Market Cap
- $2.85B
- Revenue Growth
- +13.2%
- EPS Growth
- +22.8%
- Dividend Yield
- 1.7%
Coverage: 247 bars ยท Jun 25, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Extendicare Inc. (EXETF) is a Healthcare stock with a market cap of $2.85B and listed on OTC. The stock last traded around $23.88 and up 135.7% across the available one-year price window (Jun 25, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +13.2%, EPS growth of +22.8%, a dividend yield of 1.7%. What stands out right now is revenue +13.2%, EPS +22.8%, free cash flow -37.7% with operating margin 8.3% and ROIC 13.6%. The dividend is present but secondary, with a yield around 1.7%. Valuation is more restrained than many high-expectation growth names at P/E 27.5 and price/sales 1.7. Stock Foundry combines EXETF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+13.2% vs +7.6% peer median
Operating Margin
Below sector median
+8.3% vs +19.4% peer median
P/E
Below sector median
27.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +13.2% and EPS at +22.8%, with operating margin around 8.3%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +8.1% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | -1.1% | +9.3% | +3.7% |
2026 Feb 26, 2026 | +8.0% | +12.2% | +9.9% | +4.3% |
2025 Aug 6, 2025 | +104.8% | -0.4% | +5.3% | +0.3% |
Benchmark Edge
EXETF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
EXETF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
EXETF Max Drawdown
-13.89%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for EXETF and SPY.
Company Overview
Extendicare Inc.
Other OTC
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; retirement living services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as contract and consulting services to third parties. It operates a network of 119 LTC homes and retirement communities, as well as home health care operations under the Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. Extendicare Inc. was founded in 1968 and is based in Markham, Canada.
- Leadership
- David E. Bacon
- IPO Date
- Jan 10, 2007
- Employees
- 23.5k
- Street Address
- 3000 Steeles Avenue East
- Mailing
- Markham, ON, L3R 4T9
- Region
- Markham, ON, CA
- Reporting Currency
- USD
- Investor Line
- 905-470-4000
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 27.5
- EV/EBITDA
- 15.4
- Price/Sales
- 1.7
- Price/Book
- 7.1
Growth
- Revenue
- +13.2%
- EPS
- +22.8%
- Free Cash Flow
- -37.7%
Profitability
- Gross Margin
- 52.4%
- Operating Margin
- 8.3%
- Net Margin
- 5.8%
- ROE
- 47.7%
- ROIC
- 13.6%
Balance Sheet
- Debt/Equity
- 0.92
- Current Ratio
- 1.37
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.